These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1183 related items for PubMed ID: 19822297

  • 1. Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma.
    Wallington-Beddoe CT, Gottlieb DJ, Garvin F, Antonenas V, Sartor MM.
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1386-93. PubMed ID: 19822297
    [Abstract] [Full Text] [Related]

  • 2. Failure to achieve a threshold dose of CD34+ CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation.
    Sartor MM, Garvin F, Antonenas V, Bradstock KF, Gottlieb DJ.
    Bone Marrow Transplant; 2007 Nov; 40(9):851-7. PubMed ID: 17704793
    [Abstract] [Full Text] [Related]

  • 3. Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
    Klaus J, Herrmann D, Breitkreutz I, Hegenbart U, Mazitschek U, Egerer G, Cremer FW, Lowenthal RM, Huesing J, Fruehauf S, Moehler T, Ho AD, Goldschmidt H.
    Eur J Haematol; 2007 Jan; 78(1):21-8. PubMed ID: 17042762
    [Abstract] [Full Text] [Related]

  • 4. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience.
    Olivieri A, Offidani M, Montanari M, Ciniero L, Cantori I, Ombrosi L, Masia CM, Centurioni R, Mancini S, Brunori M, Leoni P.
    Haematologica; 1998 Apr; 83(4):329-37. PubMed ID: 9592983
    [Abstract] [Full Text] [Related]

  • 5. CXCR4 expression on transplanted peripheral blood CD34+ cells: relationship to engraftment after autologous transplantation in a cohort of multiple myeloma patients.
    Hicks C, Isaacs A, Wong R, Chong BH.
    Ann Hematol; 2011 May; 90(5):547-55. PubMed ID: 20957366
    [Abstract] [Full Text] [Related]

  • 6. Changes in endogenous TPO levels during mobilization chemotherapy are predictive of CD34+ megakaryocyte progenitor yield and identify patients at risk of delayed platelet engraftment post-PBPC transplant.
    Maharaj D, Steinberg JP, Gouvea JV, Gieser PW.
    Bone Marrow Transplant; 1999 Mar; 23(6):539-48. PubMed ID: 10217183
    [Abstract] [Full Text] [Related]

  • 7. Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation.
    Lee S, Kim S, Kim H, Baek EJ, Jin H, Kim J, Kim HO.
    Vox Sang; 2008 Feb; 94(2):146-52. PubMed ID: 18028260
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Factors influencing engraftment in autologous peripheral hematopoetic stem cell transplantation (PBSCT).
    Ergene U, Cağirgan S, Pehlivan M, Yilmaz M, Tombuloğlu M.
    Transfus Apher Sci; 2007 Feb; 36(1):23-9. PubMed ID: 17292672
    [Abstract] [Full Text] [Related]

  • 10. Ideal body weight correlates better with engraftment after PBSC autograft than actual body weight, but is under-estimated in myeloma patients possibly due to disease-related height loss.
    Maclean PS, Parker AN, McQuaker IG, Clark AD, Farrell E, Douglas KW.
    Bone Marrow Transplant; 2007 Oct; 40(7):665-9. PubMed ID: 17646841
    [Abstract] [Full Text] [Related]

  • 11. The CD34+90+ cell dose does not predict early engraftment of autologous blood stem cells as well as the total CD34+ cell dose.
    Stewart DA, Guo D, Luider J, Auer I, Klassen J, Morris D, Chaudhry A, Brown C, Russell JA, Gluck S.
    Bone Marrow Transplant; 2000 Feb; 25(4):435-40. PubMed ID: 10723588
    [Abstract] [Full Text] [Related]

  • 12. Quantitation of primitive and lineage-committed progenitors in mobilized peripheral blood for prediction of platelet recovery post autologous transplant.
    Hogge DE, Lambie K, Sutherland HJ, Benny WB, Dalal B, Currie C, Barnett MJ, Eaves AC, Eaves CJ.
    Bone Marrow Transplant; 2000 Mar; 25(6):589-98. PubMed ID: 10734292
    [Abstract] [Full Text] [Related]

  • 13. Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization.
    Sinitsyn Y, Malone A, Mandeli J, Grosskreutz C, Osman K, Scigliano E, Shi P, Isola L.
    Cytotherapy; 2009 Mar; 11(4):457-63. PubMed ID: 19499401
    [Abstract] [Full Text] [Related]

  • 14. The importance of CD34+/CD33- cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescue.
    Millar BC, Millar JL, Shepherd V, Blackwell P, Porter H, Cunningham D, Judson I, Treleaven J, Powles RL, Catovsky D.
    Bone Marrow Transplant; 1998 Sep; 22(5):469-75. PubMed ID: 9733270
    [Abstract] [Full Text] [Related]

  • 15. Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation.
    Allan DS, Keeney M, Howson-Jan K, Popma J, Weir K, Bhatia M, Sutherland DR, Chin-Yee IH.
    Bone Marrow Transplant; 2002 Jun; 29(12):967-72. PubMed ID: 12098064
    [Abstract] [Full Text] [Related]

  • 16. In vitro megakaryocyte expansion in patients with delayed platelet engraftment after autologous stem cell transplantation.
    Drayer AL, Smit Sibinga CT, Esselink MT, de Wolf JT, Vellenga E.
    Ann Hematol; 2002 Apr; 81(4):192-7. PubMed ID: 11976820
    [Abstract] [Full Text] [Related]

  • 17. Autologous CD34+ cell transplantation for patients with advanced lymphoma: effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment.
    Koç ON, Gerson SL, Phillips GL, Cooper BW, Kutteh L, Van Zant G, Reece DE, Fox RM, Schupp JE, Tainer N, Lazarus HM.
    Bone Marrow Transplant; 1998 Feb; 21(4):337-43. PubMed ID: 9509966
    [Abstract] [Full Text] [Related]

  • 18. Platelet transfusion requirements during autologous peripheral blood progenitor cell transplantation correlate with the pretransplant platelet count.
    Bolwell BJ, Goormastic M, Andresen S, Overmoyer B, Pohlman B, Kalaycio M.
    Bone Marrow Transplant; 1997 Sep; 20(6):459-63. PubMed ID: 9313878
    [Abstract] [Full Text] [Related]

  • 19. Subsets of CD34+ hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation.
    Meldgaard Knudsen L, Jensen L, Jarlbaek L, Hansen PG, Hansen SW, Drivsholm L, Nikolaisen K, Gaarsdal E, Johnsen HE.
    Haematologica; 1999 Jun; 84(6):517-24. PubMed ID: 10366795
    [Abstract] [Full Text] [Related]

  • 20. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA, Sims-Poston L, Eldridge P, Hale GA.
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.